Not applicableStudy completedNCT00771927
What this trial is testing
Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures
Who this might be right for
Epilepsies, Partial
UCB Pharma 1,005